Drug – bio-affecting and body treating compositions – Inorganic active ingredient containing – Aluminum – calcium or magnesium element – or compound containing
Patent
1990-04-26
1991-08-27
Rose, Shep K.
Drug, bio-affecting and body treating compositions
Inorganic active ingredient containing
Aluminum, calcium or magnesium element, or compound containing
514159, 514790, A61K 3160, A61K 4700
Patent
active
050431684
ABSTRACT:
A stable, solid choline magnesium salicylte inclusion complex composition which comprises choline salicylate, magnesium salicylate and magnesium aluminum silicate, and granulation method for preparing the solid inclusion complex composition utilizing liquid salicylate is provided. The invention is also directed to methods of administering the compoitions of the invention to treat osteoarthritis, rheumatoid arthritis, and acute painful shoulder.
REFERENCES:
patent: 173607 (1876-02-01), Fehr
patent: 1113742 (1914-10-01), Bernedes et al.
patent: 1486373 (1924-03-01), Gerngross et al.
patent: 1764933 (1930-06-01), Coplans
patent: 1845486 (1932-02-01), Crossley
patent: 2101867 (1937-12-01), Miller et al.
patent: 2801951 (1957-08-01), Cooper, Jr.
patent: 2970163 (1961-01-01), Gottesman et al.
patent: 3069321 (1962-12-01), Broh-Kahn et al.
patent: 3141035 (1964-07-01), Lorz et al.
patent: 3297529 (1967-01-01), Berke
patent: 3326760 (1967-06-01), Halpern et al.
patent: 3337402 (1967-08-01), Zentner
patent: 3759980 (1973-09-01), Rosen et al.
patent: 3801613 (1974-04-01), Swimm
patent: 3898332 (1975-08-01), Swimm
patent: 3947491 (1976-03-01), Kelly et al.
patent: 3965263 (1976-06-01), Swimm
patent: 4001311 (1977-01-01), Kelly et al.
patent: 4067974 (1978-01-01), Sasmor
patent: 4098813 (1978-07-01), Kelly et al.
patent: 4147776 (1979-04-01), Kelly et al.
patent: 4338311 (1982-07-01), Heasley
patent: 4761274 (1988-08-01), Benick, Jr. et al.
McGinity et al., "Increasing Dissolution Rates of Poorly Soluble Drugs by adsorption to Montmorillonite", Drug Develop. and Industrial Pharmacy 6(1), 35-48 (1980).
McGinity et al., "Influence of a Montmorillonite Clay on the Properties of Griseofulvin Tablets", Drug Development and Industrial Pharmacy, 6(1), 49-50 (1980).
"Mechanism of Release", Drug Development and Industrial Phamacy, 8(6), 795-809(1982).
R. T. Vanderbilt Co., Inc. booklet on Veegum.
Wai et al., "Applications of the Montmorillonites in Tablet Making", Journal of Pharmaceutical Sciences, vol. 55, No. 11, Nov. 1966.
Wai et al., "Some Physicochemical Properties of the Montmorillonites", Journal of Pharmaceutical Sciences, vol. 55, No. 11, Nov. 1966.
Harris et al., "Optimization of Slow-Release Tablet Formulations Containing Montmorillomite I. Properties of Tablets", Drug Development and Industrial Pharmacy 6(4), 399-410 (1980).
Harris et al., "Optimization of Slow Release Tablet Formulations Containing Montmorillonite II. Factors Affecting Drug Release", Drug Development and Industrial Pharmacy, 8(6), 783-793 (1982).
Harris et al., "Optimization of Slow-Release Formulations Containing Montmorillomite III".
Bhalani Vinayak T.
Patel Satishchandra P.
Rose Shep K.
Sidmak Laboratories, Inc.
LandOfFree
Solid choline magnesium salicylate composition and method of pre does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Solid choline magnesium salicylate composition and method of pre, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Solid choline magnesium salicylate composition and method of pre will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1413072